Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522340 · ClinicalTrials.gov registry record · Phase 2
Exercise After an ICD
A Phase 2 study of Heart Failure, Congestive and Defibrillators, Implantable, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT00522340: Completed Phase 2 study of Heart Failure, Congestive and Defibrillators, Implantable, sponsored by University of Washington.
NCT00522340 is a Phase 2 study of Heart Failure, Congestive and Defibrillators, Implantable that has completed, run by University of Washington. The registered enrollment target is 160 participants, below the 671-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00522340, a Phase 2 study of Heart Failure, Congestive and Defibrillators, Implantable, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
An implantable cardioverter-defibrillator (ICD) is a small device that is surgically implanted in the chest or abdomen and uses electrical pulses or shocks to help control life-threatening, irregular heartbeats. Increasing aerobic exercise may provide health benefits to people with ICDs. This study will examine the effects of an exercise program on heart and lung function in people who have an ICD.
Conditions Studied
Interventions
- BEHAVIORAL Aerobic Exercise Program
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2007-11 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
What the finished NCT00522340 record still lists
NCT00522340 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 671-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Heart Failure, Congestive appearing as the primary indexed condition, and to 1 intervention - of which Aerobic Exercise Program is the first listed.
NCT00522340 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00522340 about?
NCT00522340 is a clinical study titled "Exercise After an ICD". An implantable cardioverter-defibrillator (ICD) is a small device that is surgically implanted in the chest or abdomen and uses electrical pulses or shocks to help control life-threatening, irregular heartbeats. Increasing aerobic exercise may provide health benefits to people with ICDs. This study ...
What is the current status of trial NCT00522340?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2007-11. Estimated completion is 2014-06.
What conditions does trial NCT00522340 study?
This clinical trial studies the following conditions: Heart Failure, Congestive, Defibrillators, Implantable.
What interventions are being tested in trial NCT00522340?
The interventions under investigation include: Aerobic Exercise Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00522340?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00522340 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Congestive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00522340's enrollment target sits among peer trials
160 21st of 39 higher than 19 of 39 other Heart Failure, Congestive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure, Congestive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
COMPLETED · Phase 2
-
Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).
COMPLETED · Phase 2
-
Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure
COMPLETED · Phase 2
-
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
COMPLETED · Phase 2
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia